New Delhi: PETA India the animal rights organisation, (People for Ethical Treatment of Animals) has written to DCGI...
New Delhi: The Central government on Wednesday refuted rumours on social media that Covaxin manufactured by Bharat...
Company promises to make phase III trials data analysis public soon.
Washington: Colleges and universities in the United States have asked students who received either Indian-made Covaxin...
New Delhi: A 'real-world' study of vaccinated healthcare workers has found Covishield and Covaxin could produce a...
New Delhi: Amid a shortage of Covid jabs and demands from various states to enhance production, Bharat Biotech responded...
With COVID-19 vaccination emerges as a necessary condition for travelling, Indians who have received Bharat Biotech's...
New Delhi: Bharat Biotech produced COVID vaccine Covaxin will be subjected to clinical trials of phase two and three in...
New Delhi: The Deputy Chief Minister of Delhi, Manish Sisodia, slammed the Centre's vaccine distribution policy, citing...
New Delhi: A top official of Bharat Biotech, producer of Covaxin, one of the two Covid-19 vaccines in India, said that...
New Delhi: India's expert panel has reportedly permitted Bharat Biotech to conduct further trials of its Covaxin in...
Following the Serum Institute of India's price cut of Covishield vaccine, Bharat Biotech on Thursday slashed its...
Covaxin will cost Rs 600 for state governments and 1200 for private hospitals, vaccine manufacturer Bharat Biotech...
New Delhi: As the Covid second wave is getting stronger in India, the percentage of citizens willing to take the vaccine...
